INTL, IDRA, SGI – PennyToBuck.com Watch List For Wednesday Dec. 14th, 2011
pennytobuck Newsletter
__ INTL, INTL FCStone Inc.
** On its fourth quarter fiscal 2011 results, INTL posted (Unaudited) total operating revenues of $108.1 million dollars, a 64% increase year over year while fiscal 2011 was a record year for the company in both adjusted operating revenues and adjusted net income.
INTL provides execution and advisory services in commodities, currencies and international securities. INTL`s businesses, which include the commodities advisory and transaction execution firm FCStone Group, serve more than 10,000 commercial customers in more than 100 countries through a network of offices in twelve countries around the world.
More about INTL at www.intlfcstone.com.
*************
IDRA, Idera Pharmaceuticals, Inc.
** IDRA reported that it presented new data showing that IMO-4200, a dual agonist of Toll-like receptor (TLR) 7 and TLR8, in combination with approved cancer treatments increased antitumor activity in preclinical models of lymphoma.
The presentation by IDRA`s scientists, entitled IMO-4200, a novel TLR7 and TLR8 dual agonist, enhances antitumor effect of ofatumumab, rituximab and cytotoxics in preclinical models of hematological malignancies, abstract number 3724, was made at the 53rd annual meeting of the American Society for Hematology being held in San Diego, California December 11-13, 2011.
IMO-4200 is a novel synthetic RNA-based dual agonist of TLR7 and TLR8 identified as a lead drug candidate for the treatment of hematological malignancies.
In preclinical mouse models of cancer, IMO-4200 has shown anticancer activity involving both innate and adaptive immune responses. IMO-4200, when administered in combination with approved cancer therapy drugs, rituximab, ofatumumab or bortezomib, showed significantly increased antitumor activity compared to the single-agent effects in several preclinical lymphoma models.
IDRA applies its proprietary Toll-like Receptor (TLR) drug discovery platform to create immunomodulatory drug candidates. IDRA`s TLR-targeted candidates are being developed to treat autoimmune and inflammatory diseases, cancer, and for use as vaccine adjuvants.
More about IDRA at www.iderapharma.com.
*************
SGI, Silicon Graphics International Corp.
** Leading Tokyo broadcaster WOWOW Inc. has selected and integrated a content server supplied by SGI that is forming the core of a full high definition file-based program broadcasting infrastructure system.
Until now, there had been no software, in Japan or abroad, which offered SMPTE436M Closed Captioning support, but SGI Japan designed and developed software which writes Closed Caption via an SGI server.
The content server is a highly reliable real-time file based workflow system for efficient end-to-end full high definition quality ingest, archiving, production, and broadcasting. The high capacity storage system imports and centrally manages programs, commercials, and captions from tape and file formats. When these types of content are registered, location information and other meta-data are also acquired, and thumbnails are generated, enabling central management and material asset management functions.
SGI is focused on helping customers solve their most demanding technology challenges by delivering high performance computing, server, storage, data center and cloud computing solutions and professional services.
More about SGI at www.sgi.com ********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
— The following information is a reminder of your current mailing list subscription:
You are subscribed to the following list:
pennytobuck.com
Related posts:
- IDRA – PennyToBuck.com Stock to Watch
- SGI, INTL, IDRA – Stock-PR.com Stock Watch For Wednesday Dec. 14th, 2011
- SGI, INTL, IDRA – DoubleInStocks.com Stock Watch For Wednesday Dec. 14th,
- IDRA, INTL, SGI – CRWEWallStreet.com Watch List For Wednesday Dec. 14th,